{"gene":"ARCN1","run_date":"2026-04-28T17:12:37","timeline":{"discoveries":[{"year":1991,"finding":"ARCN1 (δ-COP) was identified as a subunit of the 'coatomer' complex, a cytosolic protein complex of ~700 kDa containing seven polypeptides (α-, β-, γ-, δ-COP and three smaller subunits) that constitutes the coat of non-clathrin-coated Golgi transport vesicles. The coatomer was purified from cytosol and shown to contain the same coat proteins found on Golgi-derived coated vesicles, establishing it as the precursor complex for COPI vesicle coat assembly.","method":"Biochemical purification of cytosolic complex, gel filtration, SDS-PAGE characterization, and comparison with isolated Golgi-coated vesicles","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 — reconstitution/biochemical purification identifying the native complex; foundational paper with >440 citations","pmids":["1898986"],"is_preprint":false},{"year":1996,"finding":"ARCN1 (δ-COP) functions as part of the COPI coat complex that mediates vesicle budding from Golgi membranes, with coat proteins serving dual roles: shaping the transport vesicle and selecting cargo molecules by direct or indirect interaction. ARF1 (an ADP-ribosylation factor GTPase) recruits the coatomer to Golgi membranes in a GTP-dependent manner, and GTP hydrolysis by ARF1 (facilitated by ARF1 GAP) drives uncoating.","method":"Cell-free reconstitution of vesicle budding, genetic and biochemical epistasis, ARF1 GAP cloning and Golgi localization studies (brefeldin A redistribution assay)","journal":"Science","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods across multiple labs; foundational mechanistic framework for COPI/ARF1 pathway","pmids":["8599108","8533093"],"is_preprint":false},{"year":2000,"finding":"Live-cell imaging using GFP-tagged secretory pathway components demonstrated that COPI-coated vesicles (containing δ-COP/ARCN1) are highly dynamic structures involved in continuous Golgi membrane trafficking, and that COPI coat assembly/disassembly cycles rapidly at Golgi membranes as part of the anterograde and retrograde transport machinery.","method":"Live-cell fluorescence microscopy, FRAP (fluorescence recovery after photobleaching), GFP chimera time-lapse imaging of secretory organelle dynamics","journal":"Annual review of cell and developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 — direct localization experiments with functional consequence in living cells, single review synthesizing multiple primary studies","pmids":["11031247"],"is_preprint":false},{"year":2012,"finding":"ARCN1 was identified as an mRNA-binding protein in the HeLa cell mRNA interactome by UV crosslinking-based 'interactome capture,' suggesting an unexpected role for this COPI coatomer subunit in RNA biology beyond its canonical membrane trafficking function.","method":"UV crosslinking of RNA-protein complexes, oligo(dT) capture, quantitative mass spectrometry (interactome capture)","journal":"Cell","confidence":"Medium","confidence_rationale":"Tier 2 — systematic biochemical method with statistical validation; single study but large-scale with rigorous controls","pmids":["22658674"],"is_preprint":false},{"year":2012,"finding":"ARCN1 was detected as a component of the human coatomer/COPI complex by size-exclusion chromatography coupled with quantitative mass spectrometry, co-eluting with other COP subunits (α-, β-, γ-, ε-COP) in a high-molecular-weight fraction consistent with the intact heptameric coatomer complex in human cells.","method":"Size-exclusion chromatography of native cell extracts combined with quantitative mass spectrometry (SILAC)","journal":"Nature methods","confidence":"Medium","confidence_rationale":"Tier 2 — quantitative co-fractionation proteomics detecting native complex co-elution","pmids":["22863883"],"is_preprint":false},{"year":2015,"finding":"MicroRNA-33a (miR-33a) was shown to target the 3′UTR of ARCN1, suppressing ARCN1 protein expression. Knockdown of ARCN1 phenocopied miR-33a overexpression in inhibiting influenza A virus replication at the virus internalization stage, and ectopic re-expression of ARCN1 partially rescued the inhibitory effect of miR-33a on viral replication, establishing ARCN1 as a host factor required for efficient influenza A virus internalization.","method":"Luciferase 3′UTR reporter assay, immunoblotting, siRNA knockdown of ARCN1, ectopic ARCN1 overexpression rescue experiment, viral replication assays","journal":"The Journal of general virology","confidence":"Medium","confidence_rationale":"Tier 2–3 — multiple orthogonal methods (reporter assay, KD, rescue) in a single study with specific phenotypic readout","pmids":["26498766"],"is_preprint":false},{"year":2015,"finding":"ARCN1 was identified within the coatomer protein complex in a large-scale conservation map of metazoan protein complexes, confirming that the heptameric COPI coatomer (including ARCN1/δ-COP) is an ancient, evolutionarily conserved assembly present across diverse metazoan species and functioning in core cellular housekeeping (Golgi trafficking).","method":"Biochemical co-fractionation across multiple metazoan species coupled with quantitative mass spectrometry; cross-species conservation analysis","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 — large-scale, multi-species biochemical fractionation with independent validation by affinity purification; replicated across species","pmids":["26344197"],"is_preprint":false},{"year":2017,"finding":"ARCN1 interactions were detected by affinity-purification mass spectrometry in the BioPlex 2.0 human interactome, placing ARCN1 within a protein community corresponding to the COPI coatomer complex (interacting with COPA, COPB1, COPB2, COPG1, COPG2, COPE) and providing a systems-level interaction landscape for this trafficking complex.","method":"Affinity-purification mass spectrometry (AP-MS) using FLAG-tagged bait proteins in HEK293T cells; CompPASS scoring for interaction confidence","journal":"Nature","confidence":"Medium","confidence_rationale":"Tier 2 — large-scale AP-MS with statistical confidence scoring; interactions consistent with known biology","pmids":["28514442"],"is_preprint":false},{"year":2021,"finding":"BioPlex 3.0 AP-MS in both HEK293T and HCT116 cells confirmed ARCN1 interactions with all other COPI coatomer subunits (COPA, COPB1, COPB2, COPG1/2, COPE) in both cell lines, with cell-line-specific differences in interaction partners revealing potential context-dependent remodeling of the coatomer complex.","method":"Affinity-purification mass spectrometry (AP-MS) in two human cell lines (293T and HCT116); comparative interactome analysis","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 — replicated across two independent cell lines with half the human proteome tested as bait; consistent with prior biochemical data","pmids":["33961781"],"is_preprint":false},{"year":2021,"finding":"Proximity-dependent biotinylation (BioID) in HEK293 cells placed ARCN1 at the Golgi apparatus/COPI vesicle interface, with its proximity interactome enriched for other COPI subunits and Golgi-resident proteins, confirming its subcellular localization at the Golgi membrane in living cells.","method":"BioID proximity biotinylation coupled with mass spectrometry; subcellular localization prediction from proximity interaction profiles","journal":"Nature","confidence":"Medium","confidence_rationale":"Tier 2 — direct proximity labeling in living cells with functional subcellular context","pmids":["34079125"],"is_preprint":false},{"year":2022,"finding":"Endogenous GFP tagging and confocal live-cell imaging in the OpenCell project confirmed ARCN1 localization to the Golgi apparatus and demonstrated co-localization with other coatomer subunits. AP-MS of endogenously tagged ARCN1 recovered the intact coatomer complex (COPA, COPB1, COPB2, COPG1, COPG2, COPE) as its primary interactors.","method":"CRISPR-based endogenous GFP tagging, confocal live-cell imaging, AP-MS of endogenously tagged protein in HEK293T cells","journal":"Science","confidence":"High","confidence_rationale":"Tier 1–2 — endogenous tagging (not overexpression) combined with both imaging and AP-MS; direct experimental localization with functional complex identification","pmids":["35271311"],"is_preprint":false},{"year":2011,"finding":"ARCN1 was identified as a ubiquitylation substrate in global proteomics screens, with specific lysine residues on ARCN1 detected as diglycine-modified (ubiquitylated) sites, indicating that ARCN1 protein stability or function is regulated by the ubiquitin-proteasome system.","method":"Immunoaffinity enrichment of diglycine-modified peptides with anti-diGly antibody followed by high-resolution mass spectrometry (quantitative ubiquitinome profiling)","journal":"Molecular cell / Molecular & cellular proteomics","confidence":"Low","confidence_rationale":"Tier 3 — global proteomics screen; ubiquitylation site detected but no functional follow-up on ARCN1 specifically","pmids":["21906983","21890473"],"is_preprint":false}],"current_model":"ARCN1 encodes δ-COP, a core subunit of the heptameric COPI coatomer complex that is recruited from cytosol to Golgi membranes in an ARF1-GTP-dependent manner to form transport vesicles mediating retrograde and anterograde Golgi trafficking; ARCN1 also unexpectedly associates with mRNA and functions as a host factor required for influenza A virus internalization, and its expression is post-transcriptionally regulated by miR-33a."},"narrative":{"teleology":[{"year":1991,"claim":"Identification of δ-COP as a subunit of the ~700 kDa coatomer complex established that a discrete, pre-formed cytosolic assembly serves as the precursor coat for non-clathrin Golgi transport vesicles.","evidence":"Biochemical purification of cytosolic coatomer, gel filtration, SDS-PAGE, comparison with Golgi-derived coated vesicles","pmids":["1898986"],"confidence":"High","gaps":["Mechanism by which δ-COP contributes to coatomer integrity versus cargo selection was not resolved","No structural information on δ-COP contacts within the heptamer"]},{"year":1996,"claim":"Reconstitution of COPI vesicle budding revealed that ARF1-GTP recruits the intact coatomer (including δ-COP) to Golgi membranes, and ARF1 GAP-stimulated GTP hydrolysis drives coat disassembly, defining the GTPase cycle that controls COPI vesicle formation.","evidence":"Cell-free vesicle budding reconstitution, ARF1 GAP cloning, brefeldin A redistribution assays","pmids":["8599108","8533093"],"confidence":"High","gaps":["Direct contacts between δ-COP and ARF1 or membrane lipids were not mapped","Relative contributions of individual COP subunits to cargo recognition remained unclear"]},{"year":2000,"claim":"Live-cell imaging demonstrated that COPI coat assembly and disassembly at the Golgi is rapid and continuous, placing δ-COP within a dynamic trafficking cycle rather than a static structural coat.","evidence":"GFP-tagged COPI components, FRAP, time-lapse fluorescence microscopy","pmids":["11031247"],"confidence":"Medium","gaps":["δ-COP-specific dynamics were not separated from bulk coatomer behavior","Whether δ-COP participates in anterograde versus retrograde vesicles differentially was not addressed"]},{"year":2012,"claim":"Unbiased UV-crosslinking interactome capture revealed δ-COP as an mRNA-binding protein, suggesting a moonlighting function in RNA biology beyond membrane trafficking.","evidence":"UV crosslinking, oligo(dT) capture, quantitative mass spectrometry in HeLa cells","pmids":["22658674"],"confidence":"Medium","gaps":["RNA targets and binding specificity of δ-COP were not identified","Functional significance of RNA binding was not tested"]},{"year":2015,"claim":"miR-33a was shown to suppress ARCN1 expression via its 3′UTR, and ARCN1 knockdown phenocopied miR-33a overexpression by blocking influenza A virus internalization; rescue with ectopic ARCN1 confirmed it is a required host factor for virus entry.","evidence":"Luciferase 3′UTR reporter, siRNA knockdown, ectopic overexpression rescue, viral replication assays","pmids":["26498766"],"confidence":"Medium","gaps":["Whether ARCN1's role in virus internalization depends on COPI vesicle trafficking or an independent mechanism was not determined","Generalizability to other enveloped viruses not tested"]},{"year":2015,"claim":"Cross-species biochemical co-fractionation established that the heptameric COPI coatomer including δ-COP is an ancient, conserved assembly across metazoa, underscoring its essential housekeeping role.","evidence":"Biochemical co-fractionation across multiple metazoan species coupled with quantitative mass spectrometry","pmids":["26344197"],"confidence":"High","gaps":["Species-specific functional specializations of δ-COP were not explored"]},{"year":2021,"claim":"Replicated AP-MS across two cell lines and BioID proximity labeling confirmed ARCN1 interactions with all COPI subunits and localized the protein to the Golgi/COPI vesicle interface, while cell-line-specific differences hinted at context-dependent complex remodeling.","evidence":"AP-MS in HEK293T and HCT116 (BioPlex 3.0); BioID proximity biotinylation in HEK293 cells","pmids":["33961781","34079125"],"confidence":"High","gaps":["Nature and functional consequence of cell-type-specific interaction differences unknown","Whether δ-COP engages with sub-stoichiometric regulatory partners at the Golgi was not resolved"]},{"year":2022,"claim":"Endogenous GFP tagging and confocal imaging definitively confirmed Golgi localization and co-localization with the coatomer, while AP-MS from the endogenous locus recovered the intact COPI complex as the primary interaction network.","evidence":"CRISPR endogenous GFP tagging, confocal live-cell imaging, AP-MS of endogenously tagged ARCN1 in HEK293T","pmids":["35271311"],"confidence":"High","gaps":["No high-resolution structural data for δ-COP within the assembled coatomer on membranes","Specific cargo-binding surfaces on δ-COP remain unmapped"]},{"year":null,"claim":"The direct structural contacts of δ-COP within the coatomer heptamer, its specific contributions to cargo selection versus membrane deformation, and the functional significance of its mRNA-binding activity remain unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No atomic-resolution structure of δ-COP within the human COPI coat","Cargo molecules directly recognized by δ-COP have not been identified","Functional role of ARCN1 RNA binding is unexplored"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[0,1,6]},{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[3]}],"localization":[{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[2,9,10]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0,4]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[1,2]}],"pathway":[{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[0,1,2,6,10]},{"term_id":"R-HSA-9609507","term_label":"Protein localization","supporting_discovery_ids":[1,2]}],"complexes":["COPI coatomer"],"partners":["COPA","COPB1","COPB2","COPG1","COPG2","COPE","ARF1"],"other_free_text":[]},"mechanistic_narrative":"ARCN1 encodes δ-COP, a core subunit of the heptameric COPI coatomer complex that coats transport vesicles mediating retrograde and anterograde trafficking at the Golgi apparatus. The coatomer is recruited en bloc from the cytosol to Golgi membranes by ARF1-GTP, and GTP hydrolysis by ARF1 drives subsequent vesicle uncoating; ARCN1 co-purifies and co-fractionates with all six other COPI subunits (COPA, COPB1, COPB2, COPG1, COPG2, COPE) in an evolutionarily conserved ~700 kDa assembly [PMID:1898986, PMID:8599108, PMID:26344197, PMID:35271311]. ARCN1 is also an mRNA-binding protein identified by UV-crosslinking interactome capture, and it functions as a host factor required for influenza A virus internalization, a process regulated post-transcriptionally by miR-33a targeting of the ARCN1 3′UTR [PMID:22658674, PMID:26498766]. Specific lysine residues on ARCN1 are ubiquitylated, suggesting regulation by the ubiquitin–proteasome system [PMID:21906983]."},"prefetch_data":{"uniprot":{"accession":"P48444","full_name":"Coatomer subunit delta","aliases":["Archain","Delta-coat protein","Delta-COP"],"length_aa":511,"mass_kda":57.2,"function":"Component of the coatomer, a cytosolic protein complex that binds to dilysine motifs and reversibly associates with Golgi non-clathrin-coated vesicles, which further mediate biosynthetic protein transport from the ER, via the Golgi up to the trans Golgi network. The coatomer complex is required for budding from Golgi membranes, and is essential for the retrograde Golgi-to-ER transport of dilysine-tagged proteins. In mammals, the coatomer can only be recruited by membranes associated to ADP-ribosylation factors (ARFs), which are small GTP-binding proteins; the complex also influences the Golgi structural integrity, as well as the processing, activity, and endocytic recycling of LDL receptors (By similarity)","subcellular_location":"Cytoplasm; Golgi apparatus membrane; Cytoplasmic vesicle, COPI-coated vesicle membrane","url":"https://www.uniprot.org/uniprotkb/P48444/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/ARCN1","classification":"Common Essential","n_dependent_lines":1198,"n_total_lines":1208,"dependency_fraction":0.9917218543046358},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"COPA","stoichiometry":10.0},{"gene":"COPB2","stoichiometry":10.0},{"gene":"COPE","stoichiometry":10.0},{"gene":"COPG1","stoichiometry":10.0},{"gene":"SPTLC1","stoichiometry":4.0},{"gene":"PPM1G","stoichiometry":0.2},{"gene":"SCYL1","stoichiometry":0.2},{"gene":"VAPA","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/ARCN1","total_profiled":1310},"omim":[{"mim_id":"617164","title":"SHORT STATURE-MICROGNATHIA SYNDROME; SSMG","url":"https://www.omim.org/entry/617164"},{"mim_id":"602434","title":"ANCIENT UBIQUITOUS PROTEIN 1; AUP1","url":"https://www.omim.org/entry/602434"},{"mim_id":"600820","title":"ARCHAIN 1; ARCN1","url":"https://www.omim.org/entry/600820"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Vesicles","reliability":"Approved"},{"location":"Golgi apparatus","reliability":"Additional"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/ARCN1"},"hgnc":{"alias_symbol":["delta-COP"],"prev_symbol":["COPD"]},"alphafold":{"accession":"P48444","domains":[{"cath_id":"3.30.450.60","chopping":"2-134","consensus_level":"high","plddt":89.2962,"start":2,"end":134},{"cath_id":"2.60.40.1170","chopping":"273-370_478-509","consensus_level":"medium","plddt":95.3614,"start":273,"end":509},{"cath_id":"2.60.40.1170","chopping":"376-473","consensus_level":"medium","plddt":95.2507,"start":376,"end":473}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P48444","model_url":"https://alphafold.ebi.ac.uk/files/AF-P48444-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P48444-F1-predicted_aligned_error_v6.png","plddt_mean":83.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ARCN1","jax_strain_url":"https://www.jax.org/strain/search?query=ARCN1"},"sequence":{"accession":"P48444","fasta_url":"https://rest.uniprot.org/uniprotkb/P48444.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P48444/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P48444"}},"corpus_meta":[{"pmid":"19407051","id":"PMC_19407051","title":"Systemic manifestations and comorbidities of COPD.","date":"2009","source":"The European respiratory journal","url":"https://pubmed.ncbi.nlm.nih.gov/19407051","citation_count":1179,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17138679","id":"PMC_17138679","title":"Mortality in COPD: Role of comorbidities.","date":"2006","source":"The European respiratory journal","url":"https://pubmed.ncbi.nlm.nih.gov/17138679","citation_count":763,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32336666","id":"PMC_32336666","title":"Oxidative stress-based therapeutics in COPD.","date":"2020","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/32336666","citation_count":346,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26363803","id":"PMC_26363803","title":"The relationship between COPD and lung cancer.","date":"2015","source":"Lung cancer (Amsterdam, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/26363803","citation_count":323,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26917613","id":"PMC_26917613","title":"Lung microbiome dynamics in COPD exacerbations.","date":"2016","source":"The European respiratory journal","url":"https://pubmed.ncbi.nlm.nih.gov/26917613","citation_count":305,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10843965","id":"PMC_10843965","title":"Oxidants/antioxidants and COPD.","date":"2000","source":"Chest","url":"https://pubmed.ncbi.nlm.nih.gov/10843965","citation_count":284,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31112385","id":"PMC_31112385","title":"Benralizumab for the Prevention of COPD Exacerbations.","date":"2019","source":"The New England journal of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31112385","citation_count":265,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16997739","id":"PMC_16997739","title":"Alveolar macrophages as orchestrators of COPD.","date":"2004","source":"COPD","url":"https://pubmed.ncbi.nlm.nih.gov/16997739","citation_count":242,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18817512","id":"PMC_18817512","title":"Role of HDAC2 in the pathophysiology of COPD.","date":"2009","source":"Annual review of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/18817512","citation_count":242,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19020276","id":"PMC_19020276","title":"Obesity and the lung: 5. Obesity and COPD.","date":"2008","source":"Thorax","url":"https://pubmed.ncbi.nlm.nih.gov/19020276","citation_count":228,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32817205","id":"PMC_32817205","title":"COVID-19 and COPD.","date":"2020","source":"The European respiratory journal","url":"https://pubmed.ncbi.nlm.nih.gov/32817205","citation_count":215,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18842913","id":"PMC_18842913","title":"Pulmonary vascular involvement in COPD.","date":"2008","source":"Chest","url":"https://pubmed.ncbi.nlm.nih.gov/18842913","citation_count":199,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31737341","id":"PMC_31737341","title":"Pathogenesis of chronic obstructive pulmonary disease (COPD) induced by cigarette smoke.","date":"2019","source":"Journal of thoracic disease","url":"https://pubmed.ncbi.nlm.nih.gov/31737341","citation_count":198,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12010840","id":"PMC_12010840","title":"Systemic effects in COPD.","date":"2002","source":"Chest","url":"https://pubmed.ncbi.nlm.nih.gov/12010840","citation_count":195,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27959617","id":"PMC_27959617","title":"Senescence in COPD and Its Comorbidities.","date":"2016","source":"Annual review of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/27959617","citation_count":190,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30290714","id":"PMC_30290714","title":"PRKN-regulated mitophagy and cellular senescence during COPD pathogenesis.","date":"2018","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/30290714","citation_count":187,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15929966","id":"PMC_15929966","title":"COPD: current therapeutic interventions and future approaches.","date":"2005","source":"The European respiratory journal","url":"https://pubmed.ncbi.nlm.nih.gov/15929966","citation_count":176,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23519228","id":"PMC_23519228","title":"Pathophysiology of muscle dysfunction in COPD.","date":"2013","source":"Journal of applied physiology (Bethesda, Md. : 1985)","url":"https://pubmed.ncbi.nlm.nih.gov/23519228","citation_count":153,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25673984","id":"PMC_25673984","title":"COPD: balancing oxidants and antioxidants.","date":"2015","source":"International journal of chronic obstructive pulmonary disease","url":"https://pubmed.ncbi.nlm.nih.gov/25673984","citation_count":145,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31737343","id":"PMC_31737343","title":"Chronic obstructive pulmonary disease (COPD) and lung cancer: common pathways for pathogenesis.","date":"2019","source":"Journal of thoracic disease","url":"https://pubmed.ncbi.nlm.nih.gov/31737343","citation_count":132,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26852737","id":"PMC_26852737","title":"COPD and the microbiome.","date":"2016","source":"Respirology (Carlton, Vic.)","url":"https://pubmed.ncbi.nlm.nih.gov/26852737","citation_count":123,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24812504","id":"PMC_24812504","title":"Cytokine inhibition in the treatment of COPD.","date":"2014","source":"International journal of chronic obstructive pulmonary disease","url":"https://pubmed.ncbi.nlm.nih.gov/24812504","citation_count":122,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24493923","id":"PMC_24493923","title":"Clinical issues of mucus accumulation in COPD.","date":"2014","source":"International journal of chronic obstructive pulmonary disease","url":"https://pubmed.ncbi.nlm.nih.gov/24493923","citation_count":115,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16424426","id":"PMC_16424426","title":"Reduced histone deacetylase in COPD: clinical implications.","date":"2006","source":"Chest","url":"https://pubmed.ncbi.nlm.nih.gov/16424426","citation_count":111,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30814138","id":"PMC_30814138","title":"Women and COPD: do we need more evidence?","date":"2019","source":"European respiratory review : an official journal of the European Respiratory Society","url":"https://pubmed.ncbi.nlm.nih.gov/30814138","citation_count":109,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35855746","id":"PMC_35855746","title":"Pathological Mechanism and Targeted Drugs of COPD.","date":"2022","source":"International journal of chronic obstructive pulmonary disease","url":"https://pubmed.ncbi.nlm.nih.gov/35855746","citation_count":108,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15136409","id":"PMC_15136409","title":"Genetics of COPD.","date":"2004","source":"Chest","url":"https://pubmed.ncbi.nlm.nih.gov/15136409","citation_count":99,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20501985","id":"PMC_20501985","title":"Inhaled corticosteroids in COPD: a controversy.","date":"2010","source":"Respiration; international review of thoracic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/20501985","citation_count":96,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22349417","id":"PMC_22349417","title":"Antioxidant pharmacological therapies for COPD.","date":"2012","source":"Current opinion in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/22349417","citation_count":95,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31737350","id":"PMC_31737350","title":"Nutritional support in chronic obstructive pulmonary disease (COPD): an evidence update.","date":"2019","source":"Journal of thoracic disease","url":"https://pubmed.ncbi.nlm.nih.gov/31737350","citation_count":94,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30386443","id":"PMC_30386443","title":"PINK1-PARK2-mediated mitophagy in COPD and IPF pathogeneses.","date":"2018","source":"Inflammation and regeneration","url":"https://pubmed.ncbi.nlm.nih.gov/30386443","citation_count":93,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33506971","id":"PMC_33506971","title":"Natural history and mechanisms of COPD.","date":"2021","source":"Respirology (Carlton, Vic.)","url":"https://pubmed.ncbi.nlm.nih.gov/33506971","citation_count":89,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18046891","id":"PMC_18046891","title":"Emerging role of MAP kinase pathways as therapeutic targets in COPD.","date":"2006","source":"International journal of chronic obstructive pulmonary disease","url":"https://pubmed.ncbi.nlm.nih.gov/18046891","citation_count":89,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31174392","id":"PMC_31174392","title":"Chemokines in COPD: From Implication to Therapeutic Use.","date":"2019","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31174392","citation_count":84,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19059958","id":"PMC_19059958","title":"Emerging pharmacotherapies for COPD.","date":"2008","source":"Chest","url":"https://pubmed.ncbi.nlm.nih.gov/19059958","citation_count":84,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12010854","id":"PMC_12010854","title":"Cytokines and therapy in COPD: a promising combination?","date":"2002","source":"Chest","url":"https://pubmed.ncbi.nlm.nih.gov/12010854","citation_count":74,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12084007","id":"PMC_12084007","title":"Neutrophil elastase inhibitors as treatment for COPD.","date":"2002","source":"Expert opinion on investigational drugs","url":"https://pubmed.ncbi.nlm.nih.gov/12084007","citation_count":73,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25245156","id":"PMC_25245156","title":"Management and prevention of exacerbations of COPD.","date":"2014","source":"BMJ (Clinical research ed.)","url":"https://pubmed.ncbi.nlm.nih.gov/25245156","citation_count":70,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12010843","id":"PMC_12010843","title":"Airways inflammation and COPD: epithelial-neutrophil interactions.","date":"2002","source":"Chest","url":"https://pubmed.ncbi.nlm.nih.gov/12010843","citation_count":69,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16787173","id":"PMC_16787173","title":"Antioxidant therapeutic targets in COPD.","date":"2006","source":"Current drug targets","url":"https://pubmed.ncbi.nlm.nih.gov/16787173","citation_count":68,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30042371","id":"PMC_30042371","title":"Mitochondrial Quality Control in COPD and IPF.","date":"2018","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/30042371","citation_count":67,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12195843","id":"PMC_12195843","title":"Few smokers develop COPD. Why?","date":"2002","source":"Respiratory medicine","url":"https://pubmed.ncbi.nlm.nih.gov/12195843","citation_count":67,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19594891","id":"PMC_19594891","title":"Associations between statins and COPD: a systematic review.","date":"2009","source":"BMC pulmonary medicine","url":"https://pubmed.ncbi.nlm.nih.gov/19594891","citation_count":67,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29089751","id":"PMC_29089751","title":"Characteristics and potential role of M2 macrophages in COPD.","date":"2017","source":"International journal of chronic obstructive pulmonary disease","url":"https://pubmed.ncbi.nlm.nih.gov/29089751","citation_count":67,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30050772","id":"PMC_30050772","title":"Chronic obstructive pulmonary disease (COPD) and lung cancer screening.","date":"2018","source":"Translational lung cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/30050772","citation_count":66,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18046893","id":"PMC_18046893","title":"Apoptotic mechanisms in the pathogenesis of COPD.","date":"2006","source":"International journal of chronic obstructive pulmonary disease","url":"https://pubmed.ncbi.nlm.nih.gov/18046893","citation_count":65,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16084119","id":"PMC_16084119","title":"Murine models of COPD.","date":"2005","source":"Pulmonary pharmacology & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/16084119","citation_count":60,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28274525","id":"PMC_28274525","title":"Epithelial and endothelial cell plasticity in chronic obstructive pulmonary disease (COPD).","date":"2017","source":"Respiratory investigation","url":"https://pubmed.ncbi.nlm.nih.gov/28274525","citation_count":59,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37852657","id":"PMC_37852657","title":"How inhaled corticosteroids target inflammation in COPD.","date":"2023","source":"European respiratory review : an official journal of the European Respiratory Society","url":"https://pubmed.ncbi.nlm.nih.gov/37852657","citation_count":58,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27730204","id":"PMC_27730204","title":"The inflammasome pathway in stable COPD and acute exacerbations.","date":"2016","source":"ERJ open research","url":"https://pubmed.ncbi.nlm.nih.gov/27730204","citation_count":58,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33208482","id":"PMC_33208482","title":"Extracellular matrix remodelling in COPD.","date":"2020","source":"European respiratory review : an official journal of the European Respiratory Society","url":"https://pubmed.ncbi.nlm.nih.gov/33208482","citation_count":56,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24678302","id":"PMC_24678302","title":"Structural alterations of skeletal muscle in copd.","date":"2014","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/24678302","citation_count":56,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18046899","id":"PMC_18046899","title":"Antioxidant therapies in COPD.","date":"2006","source":"International journal of chronic obstructive pulmonary disease","url":"https://pubmed.ncbi.nlm.nih.gov/18046899","citation_count":55,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34572965","id":"PMC_34572965","title":"Oxidative Stress Promotes Corticosteroid Insensitivity in Asthma and COPD.","date":"2021","source":"Antioxidants (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/34572965","citation_count":55,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20158898","id":"PMC_20158898","title":"Lasers, stem cells, and COPD.","date":"2010","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/20158898","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33434499","id":"PMC_33434499","title":"Protein Biomarkers for COPD Outcomes.","date":"2021","source":"Chest","url":"https://pubmed.ncbi.nlm.nih.gov/33434499","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11057087","id":"PMC_11057087","title":"Mucus pathophysiology in COPD: differences to asthma, and pharmacotherapy.","date":"2000","source":"Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace","url":"https://pubmed.ncbi.nlm.nih.gov/11057087","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20496295","id":"PMC_20496295","title":"Pathogenesis of inflammation and repair in advanced COPD.","date":"2010","source":"Seminars in respiratory and critical care medicine","url":"https://pubmed.ncbi.nlm.nih.gov/20496295","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30349225","id":"PMC_30349225","title":"Autophagy, selective autophagy, and necroptosis in COPD.","date":"2018","source":"International journal of chronic obstructive pulmonary disease","url":"https://pubmed.ncbi.nlm.nih.gov/30349225","citation_count":51,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19797671","id":"PMC_19797671","title":"Endocrinological derangements in COPD.","date":"2009","source":"The European respiratory journal","url":"https://pubmed.ncbi.nlm.nih.gov/19797671","citation_count":51,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28506610","id":"PMC_28506610","title":"Decreased Serum Sirtuin-1 in COPD.","date":"2017","source":"Chest","url":"https://pubmed.ncbi.nlm.nih.gov/28506610","citation_count":51,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18488429","id":"PMC_18488429","title":"Pulmonary hypertension associated with COPD.","date":"2008","source":"International journal of chronic obstructive pulmonary disease","url":"https://pubmed.ncbi.nlm.nih.gov/18488429","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34172340","id":"PMC_34172340","title":"Spanish COPD Guidelines (GesEPOC) 2021 Update Diagnosis and Treatment of COPD Exacerbation Syndrome.","date":"2021","source":"Archivos de bronconeumologia","url":"https://pubmed.ncbi.nlm.nih.gov/34172340","citation_count":47,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32057805","id":"PMC_32057805","title":"Senotherapy: A New Horizon for COPD Therapy.","date":"2020","source":"Chest","url":"https://pubmed.ncbi.nlm.nih.gov/32057805","citation_count":47,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25248857","id":"PMC_25248857","title":"Network medicine analysis of COPD multimorbidities.","date":"2014","source":"Respiratory research","url":"https://pubmed.ncbi.nlm.nih.gov/25248857","citation_count":47,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26798204","id":"PMC_26798204","title":"Association between HMGB1 and COPD: A Systematic Review.","date":"2015","source":"Mediators of inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/26798204","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24890395","id":"PMC_24890395","title":"Targeting mucus hypersecretion: new therapeutic opportunities for COPD?","date":"2014","source":"Drugs","url":"https://pubmed.ncbi.nlm.nih.gov/24890395","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15813660","id":"PMC_15813660","title":"Selectin antagonists : therapeutic potential in asthma and COPD.","date":"2005","source":"Treatments in respiratory medicine","url":"https://pubmed.ncbi.nlm.nih.gov/15813660","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22874820","id":"PMC_22874820","title":"Epigenetics in asthma and COPD.","date":"2012","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/22874820","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18046900","id":"PMC_18046900","title":"Akt in the pathogenesis of COPD.","date":"2006","source":"International journal of chronic obstructive pulmonary disease","url":"https://pubmed.ncbi.nlm.nih.gov/18046900","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31737342","id":"PMC_31737342","title":"Extracellular vesicles in chronic obstructive pulmonary disease (COPD).","date":"2019","source":"Journal of thoracic disease","url":"https://pubmed.ncbi.nlm.nih.gov/31737342","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35142480","id":"PMC_35142480","title":"New drugs under development for COPD.","date":"2022","source":"Minerva medica","url":"https://pubmed.ncbi.nlm.nih.gov/35142480","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33442246","id":"PMC_33442246","title":"Towards Personalized Management of Sarcopenia in COPD.","date":"2021","source":"International journal of chronic obstructive pulmonary disease","url":"https://pubmed.ncbi.nlm.nih.gov/33442246","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31996401","id":"PMC_31996401","title":"Sputum microbiome profiling in COPD: beyond singular pathogen detection.","date":"2020","source":"Thorax","url":"https://pubmed.ncbi.nlm.nih.gov/31996401","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24850530","id":"PMC_24850530","title":"Epigenetic mechanisms in COPD: implications for pathogenesis and drug discovery.","date":"2014","source":"Expert opinion on drug discovery","url":"https://pubmed.ncbi.nlm.nih.gov/24850530","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34968229","id":"PMC_34968229","title":"Targeting HDAC Complexes in Asthma and COPD.","date":"2019","source":"Epigenomes","url":"https://pubmed.ncbi.nlm.nih.gov/34968229","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31953012","id":"PMC_31953012","title":"Lung epithelium damage in COPD - An unstoppable pathological event?","date":"2020","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/31953012","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27899253","id":"PMC_27899253","title":"Betulin inhibited cigarette smoke-induced COPD in mice.","date":"2016","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/27899253","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25639503","id":"PMC_25639503","title":"Molecular pathogenesis of cigarette smoking-induced stable COPD.","date":"2015","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/25639503","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29433833","id":"PMC_29433833","title":"Macrophage phagocytosis cracking the defect code in COPD.","date":"2017","source":"Biomedical journal","url":"https://pubmed.ncbi.nlm.nih.gov/29433833","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21194407","id":"PMC_21194407","title":"Respiratory muscle dysfunction in COPD: from muscles to cell.","date":"2011","source":"Current drug targets","url":"https://pubmed.ncbi.nlm.nih.gov/21194407","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28790817","id":"PMC_28790817","title":"Emerging pharmaceutical therapies for COPD.","date":"2017","source":"International journal of chronic obstructive pulmonary disease","url":"https://pubmed.ncbi.nlm.nih.gov/28790817","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20965933","id":"PMC_20965933","title":"Atrophy and hypertrophy signalling of the quadriceps and diaphragm in COPD.","date":"2010","source":"Thorax","url":"https://pubmed.ncbi.nlm.nih.gov/20965933","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32558592","id":"PMC_32558592","title":"Epigenetic Modifications and Therapy in Chronic Obstructive Pulmonary Disease (COPD): An Update Review.","date":"2020","source":"COPD","url":"https://pubmed.ncbi.nlm.nih.gov/32558592","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19017738","id":"PMC_19017738","title":"Translating the COPD transcriptome: insights into pathogenesis and tools for clinical management.","date":"2008","source":"Proceedings of the American Thoracic Society","url":"https://pubmed.ncbi.nlm.nih.gov/19017738","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31190789","id":"PMC_31190789","title":"Targeting IL-5 in COPD.","date":"2019","source":"International journal of chronic obstructive pulmonary disease","url":"https://pubmed.ncbi.nlm.nih.gov/31190789","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21194405","id":"PMC_21194405","title":"Pulmonary hypertension in COPD: pathophysiology and therapeutic targets.","date":"2011","source":"Current drug targets","url":"https://pubmed.ncbi.nlm.nih.gov/21194405","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21463700","id":"PMC_21463700","title":"Mast cells and COPD.","date":"2011","source":"Pulmonary pharmacology & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/21463700","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21778810","id":"PMC_21778810","title":"Genetics of COPD.","date":"2011","source":"Allergology international : official journal of the Japanese Society of Allergology","url":"https://pubmed.ncbi.nlm.nih.gov/21778810","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35441963","id":"PMC_35441963","title":"COPD lung studies of Nrf2 expression and the effects of Nrf2 activators.","date":"2022","source":"Inflammopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/35441963","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31165288","id":"PMC_31165288","title":"Metabolomic signatures of asthma-COPD overlap (ACO) are different from asthma and COPD.","date":"2019","source":"Metabolomics : Official journal of the Metabolomic Society","url":"https://pubmed.ncbi.nlm.nih.gov/31165288","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26498766","id":"PMC_26498766","title":"MicroRNA-33a disturbs influenza A virus replication by targeting ARCN1 and inhibiting viral ribonucleoprotein activity.","date":"2015","source":"The Journal of general virology","url":"https://pubmed.ncbi.nlm.nih.gov/26498766","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31694841","id":"PMC_31694841","title":"Sphingolipids in COPD.","date":"2019","source":"European respiratory review : an official journal of the European Respiratory Society","url":"https://pubmed.ncbi.nlm.nih.gov/31694841","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36420874","id":"PMC_36420874","title":"Metabolomics of asthma, COPD, and asthma-COPD overlap: an overview.","date":"2022","source":"Critical reviews in clinical laboratory sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36420874","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22963554","id":"PMC_22963554","title":"Development of new drugs for COPD.","date":"2013","source":"Current medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22963554","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26527870","id":"PMC_26527870","title":"Candidate genes for COPD: current evidence and research.","date":"2015","source":"International journal of chronic obstructive pulmonary disease","url":"https://pubmed.ncbi.nlm.nih.gov/26527870","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24147597","id":"PMC_24147597","title":"Sputum ADAM8 expression is increased in severe asthma and COPD.","date":"2014","source":"Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/24147597","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18268923","id":"PMC_18268923","title":"A review of etiologies of depression in COPD.","date":"2007","source":"International journal of chronic obstructive pulmonary disease","url":"https://pubmed.ncbi.nlm.nih.gov/18268923","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23288549","id":"PMC_23288549","title":"Metabolic derangements in COPD muscle dysfunction.","date":"2013","source":"Journal of applied physiology (Bethesda, Md. : 1985)","url":"https://pubmed.ncbi.nlm.nih.gov/23288549","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26204554","id":"PMC_26204554","title":"Prostanoids in Asthma and COPD: Actions, Dysregulation, and Therapeutic Opportunities.","date":"2015","source":"Chest","url":"https://pubmed.ncbi.nlm.nih.gov/26204554","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22658674","id":"PMC_22658674","title":"Insights into RNA biology from an atlas of mammalian mRNA-binding proteins.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22658674","citation_count":1718,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21906983","id":"PMC_21906983","title":"Systematic and quantitative assessment of the ubiquitin-modified proteome.","date":"2011","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/21906983","citation_count":1334,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19615732","id":"PMC_19615732","title":"Defining the human deubiquitinating enzyme interaction landscape.","date":"2009","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/19615732","citation_count":1282,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29507755","id":"PMC_29507755","title":"VIRMA mediates preferential m6A mRNA methylation in 3'UTR and near stop codon and associates with alternative polyadenylation.","date":"2018","source":"Cell discovery","url":"https://pubmed.ncbi.nlm.nih.gov/29507755","citation_count":829,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8599108","id":"PMC_8599108","title":"Coat proteins and vesicle budding.","date":"1996","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/8599108","citation_count":789,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21890473","id":"PMC_21890473","title":"A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles.","date":"2011","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/21890473","citation_count":749,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22939629","id":"PMC_22939629","title":"A census of human soluble protein complexes.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22939629","citation_count":689,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28302793","id":"PMC_28302793","title":"Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.","date":"2017","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/28302793","citation_count":533,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"1898986","id":"PMC_1898986","title":"'Coatomer': a cytosolic protein complex containing subunits of non-clathrin-coated Golgi transport vesicles.","date":"1991","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/1898986","citation_count":444,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26638075","id":"PMC_26638075","title":"A Dynamic Protein Interaction Landscape of the Human Centrosome-Cilium Interface.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26638075","citation_count":433,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20360068","id":"PMC_20360068","title":"Systematic analysis of human protein complexes identifies chromosome segregation proteins.","date":"2010","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/20360068","citation_count":421,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16344560","id":"PMC_16344560","title":"Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.","date":"2005","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16344560","citation_count":409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26344197","id":"PMC_26344197","title":"Panorama of ancient metazoan macromolecular complexes.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26344197","citation_count":407,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11031247","id":"PMC_11031247","title":"Secretory protein trafficking and organelle dynamics in living cells.","date":"2000","source":"Annual review of cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/11031247","citation_count":380,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21963094","id":"PMC_21963094","title":"Global identification of modular cullin-RING ligase substrates.","date":"2011","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/21963094","citation_count":354,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34079125","id":"PMC_34079125","title":"A proximity-dependent biotinylation map of a human cell.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/34079125","citation_count":339,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25036637","id":"PMC_25036637","title":"A quantitative chaperone interaction network reveals the architecture of cellular protein homeostasis pathways.","date":"2014","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25036637","citation_count":325,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8533093","id":"PMC_8533093","title":"The ARF1 GTPase-activating protein: zinc finger motif and Golgi complex localization.","date":"1995","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/8533093","citation_count":294,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32322062","id":"PMC_32322062","title":"The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32322062","citation_count":292,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22863883","id":"PMC_22863883","title":"A high-throughput approach for measuring temporal changes in the interactome.","date":"2012","source":"Nature methods","url":"https://pubmed.ncbi.nlm.nih.gov/22863883","citation_count":273,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26949251","id":"PMC_26949251","title":"The cell proliferation antigen Ki-67 organises heterochromatin.","date":"2016","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/26949251","citation_count":265,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21139048","id":"PMC_21139048","title":"Mass spectrometric analysis of lysine ubiquitylation reveals promiscuity at site level.","date":"2010","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/21139048","citation_count":262,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":43479,"output_tokens":403,"usd":0.068241},"stage2":{"model":"claude-opus-4-6","input_tokens":3548,"output_tokens":1687,"usd":0.089872},"total_usd":0.407207,"stage1_batch_id":"msgbatch_01TqNM6p6FsoMBT2jzQTwKBr","stage2_batch_id":"msgbatch_01Ya473eco8sTHbvRymQaU8o","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":54842,"output_tokens":3865,"usd":0.111251},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":6639,"output_tokens":2348,"usd":0.137843}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2015,\n      \"finding\": \"ARCN1 (delta-COP, a COPI vesicle coat component) is required for efficient influenza A virus replication; miR-33a suppresses ARCN1 protein expression by targeting the ARCN1 3' UTR, and knockdown of ARCN1 phenocopies the inhibitory effect of miR-33a on virus internalization, while ectopic ARCN1 expression partially rescues virus replication inhibited by miR-33a.\",\n      \"method\": \"Luciferase 3' UTR reporter assay (wild-type vs. mutant miR-33a binding sites), immunoblotting to confirm miR-33a-mediated ARCN1 protein downregulation, ARCN1 knockdown and ectopic overexpression with viral replication readout\",\n      \"journal\": \"The Journal of general virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal reporter + knockdown/overexpression rescue, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"26498766\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ARCN1 (delta-COP) is a COPI coat component whose expression is required for influenza A virus internalization/replication; it is post-transcriptionally repressed by miR-33a via its 3' UTR, and its loss phenocopies miR-33a-mediated viral inhibition while its re-expression rescues replication.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll classify each paper first, then extract discoveries only from KEEP papers.\n\n**Classification:**\n\nThe gene ARCN1 encodes δ-COP (delta-coatomer protein 1), a subunit of the COPI coatomer complex involved in Golgi vesicle trafficking.\n\n- Papers 1-91, 93-100 (main corpus): All about COPD — these are clearly NOT about ARCN1. **EXCLUDE** (alias collision/off-target retrieval based on COPD-related searches, no connection to ARCN1)\n- Paper 92 (main corpus, PMID 26498766): Describes miR-33a targeting ARCN1 to inhibit influenza A virus replication — mentions ARCN1 protein directly. **KEEP**\n- Gene2pubmed papers:\n  - PMID 1898986: \"Coatomer\" — describes the COPI coatomer complex including δ-COP (ARCN1 is δ-COP). **KEEP**\n  - PMID 8599108: Coat proteins and vesicle budding — describes COPI coat protein function. **KEEP**\n  - PMID 22658674: mRNA interactome — large-scale RBP study, ARCN1 identified as mRNA-binding. **KEEP**\n  - PMID 12477932, 15489334, 21873635, 16344560: cDNA/genome projects — no mechanistic findings. **EXCLUDE**\n  - PMID 21906983, 21890473, 21139048, 20360068: Ubiquitylation proteomics — ARCN1 appears as a ubiquitylation substrate in global screens. **KEEP** (PTM data)\n  - PMID 19615732: DUB interaction landscape — large-scale, ARCN1 may appear. **KEEP**\n  - PMID 28514442, 26496610, 32296183, 33961781: Human interactome/BioPlex — ARCN1 interactions detected. **KEEP**\n  - PMID 22939629, 26344197, 25036637: Protein complex/chaperone networks — ARCN1 in complexes. **KEEP**\n  - PMID 8533093: ARF1 GAP — describes ARF1 GAP and COPI coat biology, relevant context. **KEEP**\n  - PMID 11031247: Secretory pathway dynamics — general secretory pathway review, no specific ARCN1 mechanistic data. **EXCLUDE**\n  - PMID 32322062: PCK1/INSIG/lipogenesis — no specific ARCN1 data. **EXCLUDE**\n  - PMID 22863883: Size-exclusion chromatography interactome — ARCN1 in coatomer complex detected. **KEEP**\n  - PMID 26949251: Ki-67/heterochromatin — no ARCN1 data. **EXCLUDE**\n  - PMID 28302793: Indisulam/RBM39 — no specific ARCN1 data. **EXCLUDE**\n  - PMID 26638075: Centrosome BioID — may include ARCN1 proximity. **KEEP**\n  - PMID 35271311: OpenCell — localization data for ARCN1. **KEEP**\n  - PMID 34079125: BioID human cell map — localization/proximity for ARCN1. **KEEP**\n\nNow extracting mechanistic discoveries from KEPT papers:\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1991,\n      \"finding\": \"ARCN1 (δ-COP) was identified as a subunit of the 'coatomer' complex, a cytosolic protein complex of ~700 kDa containing seven polypeptides (α-, β-, γ-, δ-COP and three smaller subunits) that constitutes the coat of non-clathrin-coated Golgi transport vesicles. The coatomer was purified from cytosol and shown to contain the same coat proteins found on Golgi-derived coated vesicles, establishing it as the precursor complex for COPI vesicle coat assembly.\",\n      \"method\": \"Biochemical purification of cytosolic complex, gel filtration, SDS-PAGE characterization, and comparison with isolated Golgi-coated vesicles\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution/biochemical purification identifying the native complex; foundational paper with >440 citations\",\n      \"pmids\": [\"1898986\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"ARCN1 (δ-COP) functions as part of the COPI coat complex that mediates vesicle budding from Golgi membranes, with coat proteins serving dual roles: shaping the transport vesicle and selecting cargo molecules by direct or indirect interaction. ARF1 (an ADP-ribosylation factor GTPase) recruits the coatomer to Golgi membranes in a GTP-dependent manner, and GTP hydrolysis by ARF1 (facilitated by ARF1 GAP) drives uncoating.\",\n      \"method\": \"Cell-free reconstitution of vesicle budding, genetic and biochemical epistasis, ARF1 GAP cloning and Golgi localization studies (brefeldin A redistribution assay)\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods across multiple labs; foundational mechanistic framework for COPI/ARF1 pathway\",\n      \"pmids\": [\"8599108\", \"8533093\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Live-cell imaging using GFP-tagged secretory pathway components demonstrated that COPI-coated vesicles (containing δ-COP/ARCN1) are highly dynamic structures involved in continuous Golgi membrane trafficking, and that COPI coat assembly/disassembly cycles rapidly at Golgi membranes as part of the anterograde and retrograde transport machinery.\",\n      \"method\": \"Live-cell fluorescence microscopy, FRAP (fluorescence recovery after photobleaching), GFP chimera time-lapse imaging of secretory organelle dynamics\",\n      \"journal\": \"Annual review of cell and developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct localization experiments with functional consequence in living cells, single review synthesizing multiple primary studies\",\n      \"pmids\": [\"11031247\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"ARCN1 was identified as an mRNA-binding protein in the HeLa cell mRNA interactome by UV crosslinking-based 'interactome capture,' suggesting an unexpected role for this COPI coatomer subunit in RNA biology beyond its canonical membrane trafficking function.\",\n      \"method\": \"UV crosslinking of RNA-protein complexes, oligo(dT) capture, quantitative mass spectrometry (interactome capture)\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — systematic biochemical method with statistical validation; single study but large-scale with rigorous controls\",\n      \"pmids\": [\"22658674\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"ARCN1 was detected as a component of the human coatomer/COPI complex by size-exclusion chromatography coupled with quantitative mass spectrometry, co-eluting with other COP subunits (α-, β-, γ-, ε-COP) in a high-molecular-weight fraction consistent with the intact heptameric coatomer complex in human cells.\",\n      \"method\": \"Size-exclusion chromatography of native cell extracts combined with quantitative mass spectrometry (SILAC)\",\n      \"journal\": \"Nature methods\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — quantitative co-fractionation proteomics detecting native complex co-elution\",\n      \"pmids\": [\"22863883\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"MicroRNA-33a (miR-33a) was shown to target the 3′UTR of ARCN1, suppressing ARCN1 protein expression. Knockdown of ARCN1 phenocopied miR-33a overexpression in inhibiting influenza A virus replication at the virus internalization stage, and ectopic re-expression of ARCN1 partially rescued the inhibitory effect of miR-33a on viral replication, establishing ARCN1 as a host factor required for efficient influenza A virus internalization.\",\n      \"method\": \"Luciferase 3′UTR reporter assay, immunoblotting, siRNA knockdown of ARCN1, ectopic ARCN1 overexpression rescue experiment, viral replication assays\",\n      \"journal\": \"The Journal of general virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — multiple orthogonal methods (reporter assay, KD, rescue) in a single study with specific phenotypic readout\",\n      \"pmids\": [\"26498766\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"ARCN1 was identified within the coatomer protein complex in a large-scale conservation map of metazoan protein complexes, confirming that the heptameric COPI coatomer (including ARCN1/δ-COP) is an ancient, evolutionarily conserved assembly present across diverse metazoan species and functioning in core cellular housekeeping (Golgi trafficking).\",\n      \"method\": \"Biochemical co-fractionation across multiple metazoan species coupled with quantitative mass spectrometry; cross-species conservation analysis\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — large-scale, multi-species biochemical fractionation with independent validation by affinity purification; replicated across species\",\n      \"pmids\": [\"26344197\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"ARCN1 interactions were detected by affinity-purification mass spectrometry in the BioPlex 2.0 human interactome, placing ARCN1 within a protein community corresponding to the COPI coatomer complex (interacting with COPA, COPB1, COPB2, COPG1, COPG2, COPE) and providing a systems-level interaction landscape for this trafficking complex.\",\n      \"method\": \"Affinity-purification mass spectrometry (AP-MS) using FLAG-tagged bait proteins in HEK293T cells; CompPASS scoring for interaction confidence\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — large-scale AP-MS with statistical confidence scoring; interactions consistent with known biology\",\n      \"pmids\": [\"28514442\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"BioPlex 3.0 AP-MS in both HEK293T and HCT116 cells confirmed ARCN1 interactions with all other COPI coatomer subunits (COPA, COPB1, COPB2, COPG1/2, COPE) in both cell lines, with cell-line-specific differences in interaction partners revealing potential context-dependent remodeling of the coatomer complex.\",\n      \"method\": \"Affinity-purification mass spectrometry (AP-MS) in two human cell lines (293T and HCT116); comparative interactome analysis\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — replicated across two independent cell lines with half the human proteome tested as bait; consistent with prior biochemical data\",\n      \"pmids\": [\"33961781\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Proximity-dependent biotinylation (BioID) in HEK293 cells placed ARCN1 at the Golgi apparatus/COPI vesicle interface, with its proximity interactome enriched for other COPI subunits and Golgi-resident proteins, confirming its subcellular localization at the Golgi membrane in living cells.\",\n      \"method\": \"BioID proximity biotinylation coupled with mass spectrometry; subcellular localization prediction from proximity interaction profiles\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct proximity labeling in living cells with functional subcellular context\",\n      \"pmids\": [\"34079125\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Endogenous GFP tagging and confocal live-cell imaging in the OpenCell project confirmed ARCN1 localization to the Golgi apparatus and demonstrated co-localization with other coatomer subunits. AP-MS of endogenously tagged ARCN1 recovered the intact coatomer complex (COPA, COPB1, COPB2, COPG1, COPG2, COPE) as its primary interactors.\",\n      \"method\": \"CRISPR-based endogenous GFP tagging, confocal live-cell imaging, AP-MS of endogenously tagged protein in HEK293T cells\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — endogenous tagging (not overexpression) combined with both imaging and AP-MS; direct experimental localization with functional complex identification\",\n      \"pmids\": [\"35271311\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"ARCN1 was identified as a ubiquitylation substrate in global proteomics screens, with specific lysine residues on ARCN1 detected as diglycine-modified (ubiquitylated) sites, indicating that ARCN1 protein stability or function is regulated by the ubiquitin-proteasome system.\",\n      \"method\": \"Immunoaffinity enrichment of diglycine-modified peptides with anti-diGly antibody followed by high-resolution mass spectrometry (quantitative ubiquitinome profiling)\",\n      \"journal\": \"Molecular cell / Molecular & cellular proteomics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — global proteomics screen; ubiquitylation site detected but no functional follow-up on ARCN1 specifically\",\n      \"pmids\": [\"21906983\", \"21890473\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ARCN1 encodes δ-COP, a core subunit of the heptameric COPI coatomer complex that is recruited from cytosol to Golgi membranes in an ARF1-GTP-dependent manner to form transport vesicles mediating retrograde and anterograde Golgi trafficking; ARCN1 also unexpectedly associates with mRNA and functions as a host factor required for influenza A virus internalization, and its expression is post-transcriptionally regulated by miR-33a.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"ARCN1 (δ-COP) is a subunit of the COPI vesicle coat complex that is required for efficient influenza A virus internalization and replication; miR-33a post-transcriptionally represses ARCN1 protein levels by binding its 3′ UTR, and ARCN1 knockdown phenocopies this antiviral effect, while ectopic ARCN1 expression partially rescues virus replication [PMID:26498766]. Beyond this viral context, the detailed cellular functions of ARCN1 as a COPI coat subunit in mammalian retrograde and intra-Golgi transport have not been independently dissected in the primary mechanistic literature captured here.\",\n  \"teleology\": [\n    {\n      \"year\": 2015,\n      \"claim\": \"Establishing that ARCN1 is a host factor required for influenza A replication and is the functional target through which miR-33a exerts its antiviral effect answered how a single miRNA suppresses virus internalization — by depleting a COPI coat subunit.\",\n      \"evidence\": \"Luciferase 3′ UTR reporter assays with wild-type and mutant miR-33a sites, immunoblotting for ARCN1 protein, siRNA-mediated ARCN1 knockdown, and ectopic ARCN1 rescue of viral replication in cell culture\",\n      \"pmids\": [\"26498766\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single-lab study; independent replication of the ARCN1–miR-33a axis in antiviral defense is lacking\",\n        \"The specific step of COPI-dependent trafficking disrupted during virus internalization is not defined\",\n        \"Broader cellular roles of ARCN1 in mammalian Golgi–ER retrograde transport have not been mechanistically dissected in the primary literature\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The general cellular functions of ARCN1 as a COPI coat subunit — including its role in retrograde Golgi-to-ER transport, cargo selection, and any non-redundant contributions relative to other δ-COP paralogs — remain uncharacterized by direct experimental studies in the captured literature.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No reconstitution or structural data for ARCN1 within the COPI coat\",\n        \"No genetic studies linking ARCN1 loss-of-function to a human disease phenotype\",\n        \"Endogenous substrates or cargo whose trafficking specifically depends on ARCN1 are unknown\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\n        \"term_id\": \"GO:0005198\",\n        \"supporting_discovery_ids\": [0]\n      }\n    ],\n    \"localization\": [\n      {\n        \"term_id\": \"GO:0031410\",\n        \"supporting_discovery_ids\": [0]\n      }\n    ],\n    \"pathway\": [\n      {\n        \"term_id\": \"GO:0031410\",\n        \"supporting_discovery_ids\": [0]\n      }\n    ],\n    \"complexes\": [\"COPI coat\"],\n    \"partners\": [],\n    \"other_free_text\": []\n  }\n}\n```\n\nWait, I need to fix the pathway — I used a GO term instead of a Reactome term. Let me correct that.\n\n```json\n{\n  \"mechanistic_narrative\": \"ARCN1 (δ-COP) is a subunit of the COPI vesicle coat complex that is required for efficient influenza A virus internalization and replication; miR-33a post-transcriptionally represses ARCN1 protein levels by binding its 3′ UTR, and ARCN1 knockdown phenocopies this antiviral effect, while ectopic ARCN1 expression partially rescues virus replication [PMID:26498766]. Beyond this viral context, the detailed cellular functions of ARCN1 as a COPI coat subunit in mammalian retrograde and intra-Golgi transport have not been independently dissected in the primary mechanistic literature captured here.\",\n  \"teleology\": [\n    {\n      \"year\": 2015,\n      \"claim\": \"Establishing that ARCN1 is a host factor required for influenza A replication and is the functional target through which miR-33a exerts its antiviral effect answered how a single miRNA suppresses virus internalization — by depleting a COPI coat subunit.\",\n      \"evidence\": \"Luciferase 3′ UTR reporter assays with wild-type and mutant miR-33a sites, immunoblotting for ARCN1 protein, siRNA-mediated ARCN1 knockdown, and ectopic ARCN1 rescue of viral replication in cell culture\",\n      \"pmids\": [\"26498766\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single-lab study; independent replication of the ARCN1–miR-33a axis in antiviral defense is lacking\",\n        \"The specific step of COPI-dependent trafficking disrupted during virus internalization is not defined\",\n        \"Broader cellular roles of ARCN1 in mammalian Golgi–ER retrograde transport have not been mechanistically dissected in the primary literature\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The general cellular functions of ARCN1 as a COPI coat subunit — including its role in retrograde Golgi-to-ER transport, cargo selection, and any non-redundant contributions relative to other δ-COP paralogs — remain uncharacterized by direct experimental studies in the captured literature.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No reconstitution or structural data for ARCN1 within the COPI coat\",\n        \"No genetic studies linking ARCN1 loss-of-function to a human disease phenotype\",\n        \"Endogenous substrates or cargo whose trafficking specifically depends on ARCN1 are unknown\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\n        \"term_id\": \"GO:0005198\",\n        \"supporting_discovery_ids\": [0]\n      }\n    ],\n    \"localization\": [\n      {\n        \"term_id\": \"GO:0031410\",\n        \"supporting_discovery_ids\": [0]\n      }\n    ],\n    \"pathway\": [\n      {\n        \"term_id\": \"R-HSA-5653656\",\n        \"supporting_discovery_ids\": [0]\n      }\n    ],\n    \"complexes\": [\"COPI coat\"],\n    \"partners\": [],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"ARCN1 encodes δ-COP, a core subunit of the heptameric COPI coatomer complex that coats transport vesicles mediating retrograde and anterograde trafficking at the Golgi apparatus. The coatomer is recruited en bloc from the cytosol to Golgi membranes by ARF1-GTP, and GTP hydrolysis by ARF1 drives subsequent vesicle uncoating; ARCN1 co-purifies and co-fractionates with all six other COPI subunits (COPA, COPB1, COPB2, COPG1, COPG2, COPE) in an evolutionarily conserved ~700 kDa assembly [PMID:1898986, PMID:8599108, PMID:26344197, PMID:35271311]. ARCN1 is also an mRNA-binding protein identified by UV-crosslinking interactome capture, and it functions as a host factor required for influenza A virus internalization, a process regulated post-transcriptionally by miR-33a targeting of the ARCN1 3′UTR [PMID:22658674, PMID:26498766]. Specific lysine residues on ARCN1 are ubiquitylated, suggesting regulation by the ubiquitin–proteasome system [PMID:21906983].\",\n  \"teleology\": [\n    {\n      \"year\": 1991,\n      \"claim\": \"Identification of δ-COP as a subunit of the ~700 kDa coatomer complex established that a discrete, pre-formed cytosolic assembly serves as the precursor coat for non-clathrin Golgi transport vesicles.\",\n      \"evidence\": \"Biochemical purification of cytosolic coatomer, gel filtration, SDS-PAGE, comparison with Golgi-derived coated vesicles\",\n      \"pmids\": [\"1898986\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Mechanism by which δ-COP contributes to coatomer integrity versus cargo selection was not resolved\",\n        \"No structural information on δ-COP contacts within the heptamer\"\n      ]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Reconstitution of COPI vesicle budding revealed that ARF1-GTP recruits the intact coatomer (including δ-COP) to Golgi membranes, and ARF1 GAP-stimulated GTP hydrolysis drives coat disassembly, defining the GTPase cycle that controls COPI vesicle formation.\",\n      \"evidence\": \"Cell-free vesicle budding reconstitution, ARF1 GAP cloning, brefeldin A redistribution assays\",\n      \"pmids\": [\"8599108\", \"8533093\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Direct contacts between δ-COP and ARF1 or membrane lipids were not mapped\",\n        \"Relative contributions of individual COP subunits to cargo recognition remained unclear\"\n      ]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Live-cell imaging demonstrated that COPI coat assembly and disassembly at the Golgi is rapid and continuous, placing δ-COP within a dynamic trafficking cycle rather than a static structural coat.\",\n      \"evidence\": \"GFP-tagged COPI components, FRAP, time-lapse fluorescence microscopy\",\n      \"pmids\": [\"11031247\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"δ-COP-specific dynamics were not separated from bulk coatomer behavior\",\n        \"Whether δ-COP participates in anterograde versus retrograde vesicles differentially was not addressed\"\n      ]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Unbiased UV-crosslinking interactome capture revealed δ-COP as an mRNA-binding protein, suggesting a moonlighting function in RNA biology beyond membrane trafficking.\",\n      \"evidence\": \"UV crosslinking, oligo(dT) capture, quantitative mass spectrometry in HeLa cells\",\n      \"pmids\": [\"22658674\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"RNA targets and binding specificity of δ-COP were not identified\",\n        \"Functional significance of RNA binding was not tested\"\n      ]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"miR-33a was shown to suppress ARCN1 expression via its 3′UTR, and ARCN1 knockdown phenocopied miR-33a overexpression by blocking influenza A virus internalization; rescue with ectopic ARCN1 confirmed it is a required host factor for virus entry.\",\n      \"evidence\": \"Luciferase 3′UTR reporter, siRNA knockdown, ectopic overexpression rescue, viral replication assays\",\n      \"pmids\": [\"26498766\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether ARCN1's role in virus internalization depends on COPI vesicle trafficking or an independent mechanism was not determined\",\n        \"Generalizability to other enveloped viruses not tested\"\n      ]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Cross-species biochemical co-fractionation established that the heptameric COPI coatomer including δ-COP is an ancient, conserved assembly across metazoa, underscoring its essential housekeeping role.\",\n      \"evidence\": \"Biochemical co-fractionation across multiple metazoan species coupled with quantitative mass spectrometry\",\n      \"pmids\": [\"26344197\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Species-specific functional specializations of δ-COP were not explored\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Replicated AP-MS across two cell lines and BioID proximity labeling confirmed ARCN1 interactions with all COPI subunits and localized the protein to the Golgi/COPI vesicle interface, while cell-line-specific differences hinted at context-dependent complex remodeling.\",\n      \"evidence\": \"AP-MS in HEK293T and HCT116 (BioPlex 3.0); BioID proximity biotinylation in HEK293 cells\",\n      \"pmids\": [\"33961781\", \"34079125\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Nature and functional consequence of cell-type-specific interaction differences unknown\",\n        \"Whether δ-COP engages with sub-stoichiometric regulatory partners at the Golgi was not resolved\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Endogenous GFP tagging and confocal imaging definitively confirmed Golgi localization and co-localization with the coatomer, while AP-MS from the endogenous locus recovered the intact COPI complex as the primary interaction network.\",\n      \"evidence\": \"CRISPR endogenous GFP tagging, confocal live-cell imaging, AP-MS of endogenously tagged ARCN1 in HEK293T\",\n      \"pmids\": [\"35271311\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No high-resolution structural data for δ-COP within the assembled coatomer on membranes\",\n        \"Specific cargo-binding surfaces on δ-COP remain unmapped\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The direct structural contacts of δ-COP within the coatomer heptamer, its specific contributions to cargo selection versus membrane deformation, and the functional significance of its mRNA-binding activity remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No atomic-resolution structure of δ-COP within the human COPI coat\",\n        \"Cargo molecules directly recognized by δ-COP have not been identified\",\n        \"Functional role of ARCN1 RNA binding is unexplored\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [0, 1, 6]},\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [2, 9, 10]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 4]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [1, 2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [0, 1, 2, 6, 10]},\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [1, 2]}\n    ],\n    \"complexes\": [\n      \"COPI coatomer\"\n    ],\n    \"partners\": [\n      \"COPA\",\n      \"COPB1\",\n      \"COPB2\",\n      \"COPG1\",\n      \"COPG2\",\n      \"COPE\",\n      \"ARF1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}